Aug 22, 2025 • Zacks Commentary
NEUTRAL
Short-Term Pain, Long-Term Gain? 4 Quantum Stocks to Watch
IonQ, D-Wave, Rigetti and QUBT report steep Q2 losses but strengthen cash positions with major fundraising to fuel quantum growth.
Aug 22, 2025 • Benzinga
NEUTRAL
UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System - AstraZeneca ( NASDAQ:AZN ) , Novartis ( NYSE:NVS )
UK drug rebate system takes back 23% of sales above budget cap, nearly triple EU levels. The government's plan to double the share of medicine spending in GDP has been delayed until 2029. See the 6X seasonal strategy set to target this fall's biggest opportunities. Details here →
Aug 22, 2025 • Zacks Commentary
NEUTRAL
ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth
AbbVie's oncology sales climbed 4.2% in H1 2025 as new drugs offset Imbruvica declines, strengthening its long-term growth outlook.
Aug 22, 2025 • Benzinga
NEUTRAL
J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs - AstraZeneca ( NASDAQ:AZN ) , Biogen ( NASDAQ:BIIB )
Johnson & Johnson JNJ is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs proposed by the Trump administration. J&J announced its investment on Thursday, as reported by Reuters.
Aug 20, 2025 • Benzinga
NEUTRAL
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates - Ascentage Pharma Group ( NASDAQ:AAPG )
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million ( RMB217.4 million ) , primarily attributable to the expansion of NRDL coverage
Aug 20, 2025 • GlobeNewswire
NEUTRAL
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
ROCKVILLE, Md. and SUZHOU, China, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Ascentage Pharma Group International ( Ascentage Pharma ) ( NASDAQ: AAPG. HKEX: 6855 ) ( referred hereinto as "Ascentage Pharma," the "Company," "we," "us" or "our" ) , a global, commercial stage, integrated biopharmaceutical ...